They’re the seemingly miraculous solution to weight loss, helping people shed stubborn pounds that other diet and food ...

Goodpath, the virtual integrative care provider for chronic conditions, today announced direct-to-employer (DTE) and self-pay access to Wegovy®, including both injectable and newly-approved oral ...

Drugmaker sets $675 monthly list price starting Jan. 1, as shares fall 2.8% and stock slides 19% after CagriSema results.

The company aims to sell 12 million injectable semaglutide pens in the first year of launch. Read more at straitstimes.com.

Novo Nordisk will cut prices of the diabetes and weight loss drugs Ozempic, Rybelsus and Wegovy to $675 effective Jan. 1, 2027.

Adults with obesity may now move directly from Wegovy 2.4mg to 7.2mg if they need greater weight loss ...

By Dennis Thompson HealthDay ReporterMONDAY, Feb. 23, 2026 (HealthDay News) — Side effects like nausea or vomiting are common ...

HYDERABAD: Indian drugmaker Dr Reddy's Laboratories hopes to launch a generic version of Novo Nordisk's blockbuster ...

The Tennessee Poison Center is seeing a sharp increase in calls related to tirzepatide and semaglutide exposure — two FDA-approved medications used for weight management and treating type two ...

Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s blockbuster weight-loss drug Wegovy at a competitive ...

The Danish drugmaker released a promising update about a trial in China, but that didn’t end a rough run for shares.

Dame Prue Leith has admitted she had to quit using weight-loss jabs after just a month. The former Great British Bake Off judge said she couldn’t contemplate "a life without hunger" during her brief ...